BPC-157 · Mechanism of Action
Mechanism of Action
In published research, BPC-157 (Body Protection Compound 157 (BPC-157)) is characterized as a research peptide that is studied primarily through its interaction with nitric-oxide (eNOS) signaling. The summary below describes the mechanisms reported in the scientific literature at a molecular level. It is educational reference information about laboratory study models, not a description of effects in humans.
Reported molecular targets
The research literature associates BPC-157 with nitric-oxide (eNOS) signaling, VEGFR2-mediated angiogenesis, and FAK–paxillin cytoskeletal signaling. These are the interaction points most frequently referenced when the compound is discussed in mechanistic studies.
As with any research material, the precise pathways reported vary by model system, and findings are drawn from in-vitro and preclinical work rather than human data.
- Primary target
- nitric-oxide (eNOS) signaling
- Also referenced
- VEGFR2-mediated angiogenesis
- Also referenced
- FAK–paxillin cytoskeletal signaling
Where this mechanism is studied
Mechanistic work involving BPC-157 appears most often in the context of tissue-repair models, gut-integrity research, and tendon and ligament models. Investigators use these model systems to characterize the compound's behavior, not to establish any human application.
Blueprint Labs supplies BPC-157 as a lyophilized powder (≥98% (HPLC + LC-MS verified)) for exactly this kind of controlled laboratory study.
Reading this responsibly
Mechanistic descriptions summarize what researchers have reported about molecular interactions. They are not evidence of safety or benefit in any organism, and they are not instructions for use. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Available from Blueprint Labs
BPC-157 10mg
Third-party tested, BPC-157 supplied as a research material with a certificate of analysis available.
Questions, answered
What is the reported mechanism of BPC-157?
Published research describes BPC-157 in terms of nitric-oxide (eNOS) signaling and related signaling. This is a generic summary of laboratory findings, not a statement about effects in people.
Does this describe what BPC-157 does in humans?
No. Everything here summarizes in-vitro and preclinical research models. For research use only. Not for human consumption, diagnostic, or therapeutic use.
Is BPC-157 a small molecule or a peptide?
BPC-157 is classified as a research peptide (molecular weight 1419.55 g/mol).